Jacques Epelbaum
  • E-mail :[email]
  • Phone : 33 (0)1 40 78 92 82
  • Location : Paris, France
Last update 2011-03-25 15:32:43.655

Jacques Epelbaum PhD Natural Sciences 1981

Course and current status

1/2009- Directeur de Recherche Classe Exceptionnelle Inserm

1/2008- Chairman, Centre de Psychiatrie & Neuroscience, UMR 894 Inserm UPD

9/2006- Associate professor Inserm/Université Paris Descartes

1/2006- Comité d’orientation stratégique de l’Université Paris Descartes Member

1/2006- PhD programme GC2ID Université Paris Descartes committee Member

2001-2009 Chairman Institut Fédératif de Recherches Broca-Sainte-Anne

2001-2008 Directeur de Recherche Inserm (1ere classe = 1st class professor)

2000-2007 Director UMR 549 Inserm Université Paris Descartes

1987-2000 Directeur de Recherche Inserm (2eme classe= 2nd class full professor)

1982-1986 Chargé de recherche Inserm (= associate researcher)

1979-1981 Attaché de recherche Inserm (= asssitant researcher)

1978-1979 FRM fellow, Inserm U 159  (Dr. C Kordon)

1975-1977 Killam fellow, McGill Univ. & Montreal Neurological Institute (Prof. JB Martin),

1973-1974 PhD student U 109 Inserm (Prof JC Schwartz/ Dr. C Kordon)

Scientific summary

@font-face { font-family: "Arial"; }@font-face { font-family: "Times"; }p.MsoNormal, li.MsoNormal, div.MsoNormal { margin: 0cm 0cm 0.0001pt; font-size: 12pt; font-family: "Times New Roman"; }div.Section1 { page: Section1; }

Jacques Epelbaum is chairman of the «Centre Psychiatrie et Neurosciences Inserm, UMR 894 Inserm Faculté de Médecine Université Paris Descartes à l’Hôpital Sainte-Anne à Paris ». He is also director of a research team in the Center : Neuroendocrinology of Growth & Aging. This team presently develop two scientific projects: 1) the characterisation of neuroendocrine networks which control body growth and metabolism under normal and pathological (growth retardation and eating disorders) conditions 2) the rôle of growth-involved neuromodulators (somatostatin, IGF-1) in cognitive aging.

In the past, he characterised somatostatin deficits in neurodegenerative diseases such as Alzheimer’s and Parkinson’s dementia.

 

Co-author of 251 articles indexed in Medline, over 100 reviews or book chapters, more than 400 abstracts, and 5 books, he is presently chairing the «Publication and communication committee of the Federation of European Neuroscience Societies (FENS) », he is also a member  of the Executive Committees of FENS and the International Federation for Neuroendocrinology», He has been a member of the Advisory Panel of the NIH/NIA Aging Systems and Geriatrics Study Section , was a member of the « conseil scientifique de l’association France-Alzheimer from 1986 to 2010 and has recently been elected as représentative of the scientists in the « conseil d’administration de la Fondation Plan Alzheimer ».

Image d’exemple